Insmed Statistics
Share Statistics
Insmed has 178.90M shares outstanding. The number of shares has increased by 20.12% in one year.
| Shares Outstanding | 178.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 6.59% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 174.61M |
| Failed to Deliver (FTD) Shares | 2.07K |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 13.85M, so 7.74% of the outstanding shares have been sold short.
| Short Interest | 13.85M |
| Short % of Shares Out | 7.74% |
| Short % of Float | 7.94% |
| Short Ratio (days to cover) | 11.79 |
Valuation Ratios
The PE ratio is -5.81 and the forward PE ratio is -16.58.
| PE Ratio | -5.81 |
| Forward PE | -16.58 |
| PS Ratio | 14.26 |
| Forward PS | 23.8 |
| PB Ratio | -13.11 |
| P/FCF Ratio | -7.92 |
| PEG Ratio | n/a |
Enterprise Valuation
Insmed has an Enterprise Value (EV) of 5.07B.
| EV / Earnings | -6.77 |
| EV / Sales | 16.62 |
| EV / EBITDA | -7.75 |
| EV / EBIT | -7.15 |
| EV / FCF | -9.23 |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of -3.48.
| Current Ratio | 4.12 |
| Quick Ratio | 3.75 |
| Debt / Equity | -3.48 |
| Total Debt / Capitalization | 140.31 |
| Cash Flow / Debt | -0.46 |
| Interest Coverage | -8.69 |
Financial Efficiency
Return on equity (ROE) is 2.26% and return on capital (ROIC) is -81.65%.
| Return on Equity (ROE) | 2.26% |
| Return on Assets (ROA) | -0.56% |
| Return on Capital (ROIC) | -81.65% |
| Revenue Per Employee | 334.66K |
| Profits Per Employee | -821.89K |
| Employee Count | 912 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | 2.56M |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 151.69% in the last 52 weeks. The beta is 1.12, so Insmed's price volatility has been higher than the market average.
| Beta | 1.12 |
| 52-Week Price Change | 151.69% |
| 50-Day Moving Average | 72.31 |
| 200-Day Moving Average | 57.49 |
| Relative Strength Index (RSI) | 47.45 |
| Average Volume (20 Days) | 1.55M |
Income Statement
In the last 12 months, Insmed had revenue of $305.21M and earned -$749.57M in profits. Earnings per share was $-5.34.
| Revenue | 305.21M |
| Gross Profit | 239.63M |
| Operating Income | -709.63M |
| Net Income | -749.57M |
| EBITDA | -654.74M |
| EBIT | -709.63M |
| Earnings Per Share (EPS) | -5.34 |
Balance Sheet
The company has $482.37M in cash and $1.20B in debt, giving a net cash position of -$721.62M.
| Cash & Cash Equivalents | 482.37M |
| Total Debt | 1.20B |
| Net Cash | -721.62M |
| Retained Earnings | -3.45B |
| Total Assets | 2.05B |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was -$536.25M and capital expenditures -$13.29M, giving a free cash flow of -$549.53M.
| Operating Cash Flow | -536.25M |
| Capital Expenditures | -13.29M |
| Free Cash Flow | -549.53M |
| FCF Per Share | -3.91 |
Margins
Gross margin is 78.52%, with operating and profit margins of -232.51% and -245.59%.
| Gross Margin | 78.52% |
| Operating Margin | -232.51% |
| Pretax Margin | -244.76% |
| Profit Margin | -245.59% |
| EBITDA Margin | -214.52% |
| EBIT Margin | -232.51% |
| FCF Margin | -180.05% |
Dividends & Yields
INSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.47% |
| FCF Yield | -4.29% |
Analyst Forecast
The average price target for INSM is $85.5, which is 19.5% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $85.5 |
| Price Target Difference | 19.5% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
Stock Splits
The last stock split was on Mar 3, 2011. It was a backward split with a ratio of 1:10.
| Last Split Date | Mar 3, 2011 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 4 |